Cargando…
Anesthesia for deep brain stimulation system implantation: adapted protocol for awake and asleep surgery using microelectrode recordings
PURPOSE: Deep brain stimulation (DBS), an effective treatment for movement disorders, usually involves lead implantation while the patient is awake and sedated. Recently, there has been interest in performing the procedure under general anesthesia (asleep). This report of a consecutive cohort of DBS...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Vienna
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8967743/ https://www.ncbi.nlm.nih.gov/pubmed/35212799 http://dx.doi.org/10.1007/s00701-021-05108-3 |
_version_ | 1784678896102277120 |
---|---|
author | Vesper, Jan Mainzer, Bernd Senemmar, Farhad Schnitzler, Alfons Groiss, Stefan Jun Slotty, Philipp J. |
author_facet | Vesper, Jan Mainzer, Bernd Senemmar, Farhad Schnitzler, Alfons Groiss, Stefan Jun Slotty, Philipp J. |
author_sort | Vesper, Jan |
collection | PubMed |
description | PURPOSE: Deep brain stimulation (DBS), an effective treatment for movement disorders, usually involves lead implantation while the patient is awake and sedated. Recently, there has been interest in performing the procedure under general anesthesia (asleep). This report of a consecutive cohort of DBS patients describes anesthesia protocols for both awake and asleep procedures. METHODS: Consecutive patients with Parkinson’s disease received subthalamic nucleus (STN) implants either moderately sedated or while intubated, using propofol and remifentanil. Microelectrode recordings were performed with up to five trajectories after discontinuing sedation in the awake group, or reducing sedation in the asleep group. Clinical outcome was compared between groups with the UPDRS III. RESULTS: The awake group (n = 17) received 3.5 mg/kg/h propofol and 11.6 μg/kg/h remifentanil. During recording, all anesthesia was stopped. The asleep group (n = 63) initially received 6.9 mg/kg/h propofol and 31.3 μg/kg/h remifentanil. During recording, this was reduced to 3.1 mg/kg/h propofol and 10.8 μg/kg/h remifentanil. Without parkinsonian medications or stimulation, 3-month UPDRS III ratings (ns = 16 and 52) were 40.8 in the awake group and 41.4 in the asleep group. Without medications but with stimulation turned on, ratings improved to 26.5 in the awake group and 26.3 in the asleep group. With both medications and stimulation, ratings improved further to 17.6 in the awake group and 15.3 in the asleep group. All within-group improvements from the off/off condition were statistically significant (all ps < 0.01). The degree of improvement with stimulation, with or without medications, was not significantly different in the awake vs. asleep groups (ps > 0.05). CONCLUSION: The above anesthesia protocols make possible an asleep implant procedure that can incorporate sufficient microelectrode recording. Together, this may increase patient comfort and improve clinical outcomes. |
format | Online Article Text |
id | pubmed-8967743 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Springer Vienna |
record_format | MEDLINE/PubMed |
spelling | pubmed-89677432022-04-07 Anesthesia for deep brain stimulation system implantation: adapted protocol for awake and asleep surgery using microelectrode recordings Vesper, Jan Mainzer, Bernd Senemmar, Farhad Schnitzler, Alfons Groiss, Stefan Jun Slotty, Philipp J. Acta Neurochir (Wien) Original Article - Functional Neurosurgery - Movement disorders PURPOSE: Deep brain stimulation (DBS), an effective treatment for movement disorders, usually involves lead implantation while the patient is awake and sedated. Recently, there has been interest in performing the procedure under general anesthesia (asleep). This report of a consecutive cohort of DBS patients describes anesthesia protocols for both awake and asleep procedures. METHODS: Consecutive patients with Parkinson’s disease received subthalamic nucleus (STN) implants either moderately sedated or while intubated, using propofol and remifentanil. Microelectrode recordings were performed with up to five trajectories after discontinuing sedation in the awake group, or reducing sedation in the asleep group. Clinical outcome was compared between groups with the UPDRS III. RESULTS: The awake group (n = 17) received 3.5 mg/kg/h propofol and 11.6 μg/kg/h remifentanil. During recording, all anesthesia was stopped. The asleep group (n = 63) initially received 6.9 mg/kg/h propofol and 31.3 μg/kg/h remifentanil. During recording, this was reduced to 3.1 mg/kg/h propofol and 10.8 μg/kg/h remifentanil. Without parkinsonian medications or stimulation, 3-month UPDRS III ratings (ns = 16 and 52) were 40.8 in the awake group and 41.4 in the asleep group. Without medications but with stimulation turned on, ratings improved to 26.5 in the awake group and 26.3 in the asleep group. With both medications and stimulation, ratings improved further to 17.6 in the awake group and 15.3 in the asleep group. All within-group improvements from the off/off condition were statistically significant (all ps < 0.01). The degree of improvement with stimulation, with or without medications, was not significantly different in the awake vs. asleep groups (ps > 0.05). CONCLUSION: The above anesthesia protocols make possible an asleep implant procedure that can incorporate sufficient microelectrode recording. Together, this may increase patient comfort and improve clinical outcomes. Springer Vienna 2022-02-25 2022 /pmc/articles/PMC8967743/ /pubmed/35212799 http://dx.doi.org/10.1007/s00701-021-05108-3 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Original Article - Functional Neurosurgery - Movement disorders Vesper, Jan Mainzer, Bernd Senemmar, Farhad Schnitzler, Alfons Groiss, Stefan Jun Slotty, Philipp J. Anesthesia for deep brain stimulation system implantation: adapted protocol for awake and asleep surgery using microelectrode recordings |
title | Anesthesia for deep brain stimulation system implantation: adapted protocol for awake and asleep surgery using microelectrode recordings |
title_full | Anesthesia for deep brain stimulation system implantation: adapted protocol for awake and asleep surgery using microelectrode recordings |
title_fullStr | Anesthesia for deep brain stimulation system implantation: adapted protocol for awake and asleep surgery using microelectrode recordings |
title_full_unstemmed | Anesthesia for deep brain stimulation system implantation: adapted protocol for awake and asleep surgery using microelectrode recordings |
title_short | Anesthesia for deep brain stimulation system implantation: adapted protocol for awake and asleep surgery using microelectrode recordings |
title_sort | anesthesia for deep brain stimulation system implantation: adapted protocol for awake and asleep surgery using microelectrode recordings |
topic | Original Article - Functional Neurosurgery - Movement disorders |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8967743/ https://www.ncbi.nlm.nih.gov/pubmed/35212799 http://dx.doi.org/10.1007/s00701-021-05108-3 |
work_keys_str_mv | AT vesperjan anesthesiafordeepbrainstimulationsystemimplantationadaptedprotocolforawakeandasleepsurgeryusingmicroelectroderecordings AT mainzerbernd anesthesiafordeepbrainstimulationsystemimplantationadaptedprotocolforawakeandasleepsurgeryusingmicroelectroderecordings AT senemmarfarhad anesthesiafordeepbrainstimulationsystemimplantationadaptedprotocolforawakeandasleepsurgeryusingmicroelectroderecordings AT schnitzleralfons anesthesiafordeepbrainstimulationsystemimplantationadaptedprotocolforawakeandasleepsurgeryusingmicroelectroderecordings AT groissstefanjun anesthesiafordeepbrainstimulationsystemimplantationadaptedprotocolforawakeandasleepsurgeryusingmicroelectroderecordings AT slottyphilippj anesthesiafordeepbrainstimulationsystemimplantationadaptedprotocolforawakeandasleepsurgeryusingmicroelectroderecordings |